520 S 7th St, Vincennes, IN, 47591 · (812) 882-5220
Beds
99
FY 2025
Star rating
2 of 5
Patient survey: 3 of 5
Net patient revenue
$281.8M
FY 2025
Net income
$863K
Patient care margin -13.6%
Discharges
4,550
Occupancy 50.5%
Clinicians
469
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $281.8M | $320.2M | -13.6% | $863K | 4,550 | $5.4M | 39.8% | 1.3% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 8.5% | US median 8.5% |
| Death rate for heart attack patients | 11.1% | US median 11.8% |
| Death rate for heart failure patients | 13% | US median 11% |
| Hospital-wide death rate within 30 days | 4.9% | US median 3.9% |
| Death rate for pneumonia patients | 15.6% | US median 15.2% |
| Death rate for stroke patients | 14.1% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $267.0M | $290.2M | -8.7% | -$2.4M | 4,127 | $4.2M | 42.0% | 2.6% |
| 2023 | $244.9M | $273.1M | -11.5% | -$1.6M | 4,032 | $5.5M | 42.3% | 2.6% |
| 2022 | $233.1M | $263.3M | -12.9% | -$15.7M | 4,036 | $4.3M | 45.4% | 3.5% |
| 2021 | $232.9M | $254.0M | -9.1% | $7.5M | 4,051 | $2.7M | 44.1% | 2.7% |
| 2020 | $221.0M | $243.9M | -10.3% | $10.2M | 4,855 | $7.0M | 51.8% | 2.5% |
| Readmission rate for COPD | 19.5% | US median 19.8% |
| Readmission rate after a heart attack | 15.7% | US median 14.4% |
| Readmission rate for heart failure | 20.9% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.6% | US median 5.8% |
| Readmission rate for pneumonia | 17.9% | US median 17.2% |
| Complications after hip or knee replacement | 4.6% | US median 4.1% |
| Serious complications (patient safety composite) | 0.89 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.69 | US median 0.28 |
| Central line bloodstream infections (ratio to expected) | 0.90 | US median 0.48 |
| Surgical site infections after colon surgery (ratio to expected) | 0.00 | US median 0.72 |
| Catheter urinary tract infections (ratio to expected) | 1.26 | US median 0.40 |
| Doctors always communicated well | 76% | US median 79% |
| Nurses always communicated well | 75% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 64% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 70% | US median 72% |
| Room and bathroom always clean | 77% | US median 73% |
| Patients who would definitely recommend the hospital | 67% | US median 71% |
| Patients who left the emergency department before being seen | 1% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 119 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 21% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 75% | US median 65% |
| Healthcare workers given the flu vaccine | 96% | US median 79% |
| Stroke patients who got a brain scan within 45 minutes of arrival | 87% | US median 74% |
| 52 |
| $32,786.52 |
| $9,817.67 |
| $9,867.73 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 50 | $25,439.34 | $7,534.94 | $7,681.44 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 43 | $35,046.60 | $11,642.98 | $12,400.10 |
| DRG 683 RENAL FAILURE WITH CC | 39 | $18,869.69 | $6,373.87 | $6,629.69 |
| DRG 321 PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH INTRALUMINAL DEVICE WITH MCC OR 4+ ARTERIES/ | 34 | $103,034.00 | $21,879.94 | $22,190.93 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 34 | $31,187.47 | $11,017.94 | $12,667.88 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 34 | $31,417.03 | $9,213.62 | $9,973.97 |
| DRG 309 CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC | 30 | $22,546.70 | $4,970.97 | $5,247.13 |
| DRG 481 HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH CC | 28 | $47,802.18 | $15,532.36 | $15,801.33 |
| DRG 065 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH CC OR TPA IN 24 HOURS | 28 | $34,130.82 | $7,429.68 | $7,474.08 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 26 | $28,381.92 | $7,340.54 | $7,294.77 |
| DRG 682 RENAL FAILURE WITH MCC | 25 | $35,793.92 | $10,446.20 | $11,457.18 |
| DRG 377 GASTROINTESTINAL HEMORRHAGE WITH MCC | 25 | $37,345.20 | $13,682.40 | $14,301.50 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5491 Level 1 Intraocular Procedures | 254 | 160 | $1,624.40 | $1,751.67 |
| APC 8011 Comprehensive Observation Services | 225 | 212 | $1,891.43 | $2,090.36 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 167 | 157 | $1,133.70 | $1,219.56 |
| APC 5115 Level 5 Musculoskeletal Procedures | 156 | 150 | $9,989.65 | $10,771.69 |
| APC 5191 Level 1 Endovascular Procedures | 155 | 154 | $2,034.82 | $2,207.96 |
| APC 5192 Level 2 Endovascular Procedures | 136 | 100 | $3,968.29 | $4,338.16 |
| APC 5183 Level 3 Vascular Procedures | 106 | 94 | $2,241.77 | $2,405.01 |
| APC 5431 Level 1 Nerve Procedures | 91 | 75 | $1,369.14 | $1,406.61 |
| APC 5193 Level 3 Endovascular Procedures | 82 | 73 | $7,997.92 | $8,873.86 |
| APC 5302 Level 2 Upper GI Procedures | 73 | 62 | $1,354.83 | $1,444.50 |
| APC 5113 Level 3 Musculoskeletal Procedures | 70 | 70 | $2,298.78 | $2,373.24 |
| APC 5114 Level 4 Musculoskeletal Procedures | 62 | 60 | $5,019.40 | $5,338.75 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Good Samaritan Hospital is a government-owned short-term acute care hospital in Vincennes, IN with 99 beds, part of Good Samaritan and a 2-star overall rating.
Good Samaritan Hospital in Vincennes, IN has 99 beds (fiscal year 2025 cost report); 165 beds are certified for Medicare. It discharged 4,550 inpatients that year, with 50.5% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Good Samaritan Hospital reported net patient revenue of $281.8M and operating expenses of $320.2M, a margin on patient care of -13.6%. After other income and expenses its net income was $863K (0.3% of revenue), so it made a profit that year.
Good Samaritan Hospital is part of Good Samaritan, a health system with 1 hospitals based in Vincennes, IN. It is a government-owned hospital.
Good Samaritan Hospital has an overall rating of 2 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey. 0 death rate measures are better and 1 worse than the national rate.
Yes, Good Samaritan Hospital provides emergency services.
469 Medicare clinicians list Good Samaritan Hospital as a hospital they work at, most often in Nurse Practitioner, Family Practice, Internal Medicine.
In 2024, Good Samaritan Hospital had 1,141 Medicare inpatient stays in 38 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 222 stays; Medicare paid $14,623.77 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $4,335 in payments to Good Samaritan Hospital as a teaching hospital ($4,335 general and - for research) from 5 companies.